In recent years, the media regularly report outbreaks of dangerous diseases caused by previously unknown pathogens, such as the Ebola or Zika virus. Established in 2014, the international organization CEPI (Coalition for Epidemic Preparedness Innovations) is developing vaccines to prevent their spread throughout the world. In order to speed up this usually long process, she is looking for new technologies and supports researchers who are working on them.
Recently, CubeVac AG, the Tubing company, became a partner of CEPI. In the next 3 years, its employees will be engaged in the development of vaccines against yellow fever, rabies and Lassa fever based on ribonucleic acids (RNA), designed to replace drugs with dead or weakened viruses. According to scientists, vaccines have all the advantages of the latter, but do not cause side effects.
Under the influence of RNA vaccines, cells of the body induce pathogens to place specific proteins on their surface and thus make them visible to the immune system. Prepared drugs are planned to be tested on patients during clinical trials. CEPI promises to allocate $ 34 million to scientists from Tübingen.
At the same time, the company is developing an innovative 3D printer for cheap and fast production of vaccines in large quantities. With this machine you can produce hundreds of thousands of doses in a few weeks. In addition, a 3D printer, if necessary, can be easily reconfigured to produce other drugs.
Photo source: https://pixabay.com